バイオテクノロジー試薬およびキットの世界市場規模は、2028年までに16.5%のCAGRを記録し、1兆1,400億USドルに達すると予測されています。市場を牽引する主な要因としては、革新的なで先進的な製品の導入、バイオテクノロジー分野への投資の増加、合成生物学への需要の高まりなどが挙げられます。
ライフサイエンスやバイオテクノロジー研究のための研究開発費の増加は、今後数年間で市場を大きく牽引すると予想されます。過去数十年にわたり、バイオテクノロジー分野では、新しい治療法や薬剤、生物学的に制御された生産プロセス、遺伝子組み換え食品、生物学的コンピューティング、新素材などへのパラダイムシフトが見られ、それが市場の成長を促進しています。
液滴デジタルPCR、NGS、ゲノムワイドシーケンシングなどの分子診断技術の精度、再現性、タイムラインに関する進歩は、バイオテクノロジー試薬およびキットの市場での採用に影響を与えています。ロングリードシーケンスの登場により、単一のDNA分子を読み取るだけで、より長いDNA鎖のシーケンスが可能になり、それが市場の成長を促進しています。
細胞培養技術は、主要企業が提供する膨大な製品ポートフォリオと細胞生物学研究の拡大により、2020年には最大の売上シェアを占めています。NGS技術を用いたRNA-Seqは、トランスクリプトームを調査する研究コミュニティで選択される手法として浮上しています。2020年には、細胞・遺伝子治療やワクチン療法への導入が進み、ウイルス分野が市場を席巻しました。パンデミックの発生により、ウイルスベクターを用いたワクチン開発に力が注がれており、市場の成長にプラスの影響を与えています。
2020年には、北アメリカが最大の収益シェアを獲得し、アメリカが最大の貢献者となりました。この地域では、主要企業の存在と研究活動への積極的な関与が、最大のシェアに貢献しています。アジア太平洋地域は、医療インフラの整備、大手バイオテクノロジー企業の参入、研究開発活動の活発化などにより、2021年から2028年にかけて最も速いCAGRを記録すると予測されています。世界市場の主要企業は、バイオ医薬品の開発者と協力して製品開発プロセスをサポートしています。
目次
Table of Contents
Chapter 1 Methodology and Scope
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates and forecast timeline
1.3 Research Methodology
1.4 Information Procurement
1.4.1 Purchased database
1.4.2 GVR’s internal database
1.4.3 Secondary sources
1.4.4 Primary research
1.5 Information or Data Analysis
1.5.1 Data analysis models
1.6 Market Formulation & Validation
1.7 Market Model
1.7.1 Revenue share assessment of technology
1.7.2 Revenue share assessment of kit type
1.7.3 Revenue share assessment of tested parameters
1.7.4 Revenue share assessment of end-use
1.8 Objectives
1.8.1 Objective 1:
1.8.2 Objective 2:
Chapter 2 Executive Summary
2.1 Market Summary
Chapter 3 Industry Outlook
3.1 Market Segmentation & Scope
3.2 Market Trends & Outlook
3.3 Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Increasing R&D expenditure by biotechnology companies
3.3.1.2 Growing demand for synthetic biology
3.3.1.3 Increasing applications of sequencing in molecular biology
3.3.1.4 Technological advancements in the biotechnology field
3.3.1.4.1 Sequencing
3.3.1.4.2 Amplification
3.3.1.4.3 Advancements in agriculture biotechnology
3.3.2 Market restraint analysis
3.3.2.1 High cost of advanced molecular testing equipment
3.3.2.2 Challenges associated with the implementation of NGS
3.3.2.3 Risks pertaining to the usage of genetically modified food/crops
3.3.3 Market opportunity analysis
3.3.3.1 Expanding application scope for the COVID-19 Management
3.3.4 Market challenge analysis
3.3.4.1 Challenges pertaining to molecular diagnostics
3.4 Penetration and Growth Prospect Mapping for Technology, 2020
3.5 Business Environment Analysis
3.5.1 SWOT Analysis; By factor (Political & Legal, Economic, and Technological)
3.5.2 Porter’s Five Forces Analysis
3.6 Market Entry Strategies
3.6.1 Mergers & acquisitions
3.6.2 Greenfield investment
3.7 New Technologies/Novel Product Development & Launch
3.8 List of Products in the Market
3.8.1 Key companies & their product offerings
3.8.2 Purification kits
3.8.3 Amplification kits
3.8.4 Detection kits
3.8.5 Isolation kits
3.8.6 Other kits
3.9 Brand wise Analysis
3.9.1 Key Players
3.9.2 Brand-wise pricing Analysis
3.9.3 Brand-wise sales volume, 2020
Chapter 4 Biotechnology Reagents & Kits Market: Kit Type Business Analysis
4.1 Purification Kits
4.1.1 Purification kits market estimates and forecasts, 2017 - 2028 (USD Billion)
4.2 Amplification Kits
4.2.1 Amplification kits market estimates and forecasts, 2017 - 2028 (USD Billion)
4.3 Detection Kits
4.3.1 Detection kits market estimates and forecasts, 2017 - 2028 (USD Billion)
4.4 Isolation Kits
4.4.1 Isolation kits market estimates and forecasts, 2017 - 2028 (USD Billion)
4.5 Other
4.5.1 Other kits market estimates and forecasts, 2017 - 2028 (USD Billion)
Chapter 5 Biotechnology Reagents & Kits Market: Technology Business Analysis
5.1 Biotechnology Reagents & Kits Market: Technology Movement Analysis
5.2 LAMP Technology
5.2.1 LAMP technology market estimates and forecasts, 2017 - 2028 (USD Billion)
5.3 Polymerase Chain Reaction (PCR)
5.3.1 PCR market estimates and forecasts, 2017 - 2028 (USD Billion)
5.4 Electrophoresis
5.4.1 Electrophoresis market estimates and forecasts, 2017 - 2028 (USD Billion)
5.5 Chromatography
5.5.1 Chromatography market estimates and forecasts, 2017 - 2028 (USD Billion)
5.6 Flow Cytometry
5.6.1 Flow cytometry market estimates and forecasts, 2017 - 2028 (USD Billion)
5.7 Sequencing
5.7.1 Sequencing market estimates and forecasts, 2017 - 2028 (USD Billion)
5.8 Cell Culture
5.8.1 Cell culture market estimates and forecasts, 2017 - 2028 (USD Billion)
5.9 Other Technologies
5.9.1 Other technologies market estimates and forecasts, 2017 - 2028 (USD Billion)
Chapter 6 Biotechnology Reagents & Kits Market: Tested Parameters Business Analysis
6.1 Biotechnology Reagents & Kits Market: Tested Parameters Movement Analysis
6.2 DNA
6.2.1 DNA market estimates and forecasts, 2017 - 2028 (USD Billion)
6.3 RNA
6.3.1 RNA market estimates and forecasts, 2017 - 2028 (USD Billion)
6.4 Enzymes
6.4.1 Enzymes market estimates and forecasts, 2017 - 2028 (USD Billion)
6.5 Proteins
6.5.1 Proteins market estimates and forecasts, 2017 - 2028 (USD Billion)
6.6 Others
6.6.1 Others market estimates and forecasts, 2017 - 2028 (USD Billion)
Chapter 7 Biotechnology Reagents & Kits Market: Micro-Organisms Business Analysis
7.1 Biotechnology Reagents & Kits Market: Micro-Organisms Movement Analysis
7.2 Bacteria
7.2.1 Bacteria market estimates and forecasts, 2017 - 2028 (USD Billion)
7.3 Virus
7.3.1 Virus market estimates and forecasts, 2017 - 2028 (USD Billion)
7.4 Fungi
7.4.1 Fungi market estimates and forecasts, 2017 - 2028 (USD Billion)
7.5 Parasites
7.5.1 Parasites market estimates and forecasts, 2017 - 2028 (USD Billion)
Chapter 8 Biotechnology Reagents & Kits Market: Purpose Business Analysis
8.1 Biotechnology reagents & kits market: Purpose Movement Analysis
8.2 On-Site
8.2.1 On-site market estimates and forecasts, 2017 - 2028 (USD Billion)
8.3 Laboratory
8.3.1 Laboratory market estimates and forecasts, 2017 - 2028 (USD Billion)
Chapter 9 Biotechnology Reagents & Kits Market: End-Use Business Analysis
9.1 Biotechnology reagents & kits market: End-use Movement Analysis
9.2 Healthcare
9.2.1 Healthcare market estimates and forecasts, 2017 - 2028 (USD Billion)
9.3 Food & Agriculture
9.3.1 Food & Agriculture market estimates and forecasts, 2017 - 2028 (USD Billion)
9.4 Natural Resources & Environment
9.4.1 Natural Resources & Environment market estimates and forecasts, 2017 - 2028 (USD Billion)
9.5 Industrial Processing
9.5.1 Industrial Processing market estimates and forecasts, 2017 - 2028 (USD Billion)
9.6 Others
9.6.1 Others market estimates and forecasts, 2017 - 2028 (USD Billion)
Chapter 10 Biotechnology Reagents & Kits Market: Regional Business Analysis
10.1 Biotechnology Reagents & Kits Market Share by Regional, 2020 & 2028
10.2 North America
10.2.1 North America market estimates and forecasts, 2017 - 2028 (USD Billion)
10.2.2 The U.S.
10.2.2.1 The U.S. biotechnology reagents & kits market estimates and forecast, by kit type 2017-2028 (USD Billion)
10.2.2.2 The U.S. biotechnology reagents & kits market estimates and forecast, by technology 2017-2028 (USD Billion)
10.2.2.3 The U.S. biotechnology reagents & kits market estimates and forecast, by tested parameters, 2017-2028 (USD Billion)
10.2.2.4 The U.S. biotechnology reagents & kits market estimates and forecast, by micro-organisms, 2017-2028 (USD Billion)
10.2.2.5 The U.S. biotechnology reagents & kits market estimates and forecast, by purpose, 2017-2028 (USD Billion)
10.2.2.6 The U.S. biotechnology reagents & kits market estimates and forecast, by end-use, 2017-2028 (USD Billion)
10.2.3 Canada
10.2.3.1 Canada biotechnology reagents & kits market estimates and forecast, by kit type 2017-2028 (USD Billion)
10.2.3.2 Canada biotechnology reagents & kits market estimates and forecast, by technology 2017-2028 (USD Billion)
10.2.3.3 Canada biotechnology reagents & kits market estimates and forecast, by tested parameters, 2017-2028 (USD Billion)
10.2.3.4 Canada biotechnology reagents & kits market estimates and forecast, by micro-organisms, 2017-2028 (USD Billion)
10.2.3.5 Canada biotechnology reagents & kits market estimates and forecast, by purpose, 2017-2028 (USD Billion)
10.2.3.6 Canada biotechnology reagents & kits market estimates and forecast, by end-use, 2017-2028 (USD Billion)
10.3 Europe
10.3.1 Europe market estimates and forecasts, 2017 - 2028 (USD Billion)
10.3.2 Germany
10.3.2.1 Germany biotechnology reagents & kits market estimates and forecast, by kit type 2017-2028 (USD Billion)
10.3.2.2 Germany biotechnology reagents & kits market estimates and forecast, by technology 2017-2028 (USD Billion)
10.3.2.3 Germany biotechnology reagents & kits market estimates and forecast, by tested parameters, 2017-2028 (USD Billion)
10.3.2.4 Germany biotechnology reagents & kits market estimates and forecast, by micro-organisms, 2017-2028 (USD Billion)
10.3.2.5 Germany biotechnology reagents & kits market estimates and forecast, by purpose, 2017-2028 (USD Billion)
10.3.2.6 Germany biotechnology reagents & kits market estimates and forecast, by end-use, 2017-2028 (USD Billion)
10.3.3 The U.K.
10.3.3.1 The U.K. biotechnology reagents & kits market estimates and forecast, by kit type 2017-2028 (USD Billion)
10.3.3.2 The U.K. biotechnology reagents & kits market estimates and forecast, by technology 2017-2028 (USD Billion)
10.3.3.3 The U.K. biotechnology reagents & kits market estimates and forecast, by tested parameters, 2017-2028 (USD Billion)
10.3.3.4 The U.K. biotechnology reagents & kits market estimates and forecast, by micro-organisms, 2017-2028 (USD Billion)
10.3.3.5 The U.K. biotechnology reagents & kits market estimates and forecast, by purpose, 2017-2028 (USD Billion)
10.3.3.6 The U.K. biotechnology reagents & kits market estimates and forecast, by end-use, 2017-2028 (USD Billion)
10.3.4 France
10.3.4.1 France biotechnology reagents & kits market estimates and forecast, by kit type 2017-2028 (USD Billion)
10.3.4.2 France biotechnology reagents & kits market estimates and forecast, by technology 2017-2028 (USD Billion)
10.3.4.3 France biotechnology reagents & kits market estimates and forecast, by tested parameters, 2017-2028 (USD Billion)
10.3.4.4 France biotechnology reagents & kits market estimates and forecast, by micro-organisms, 2017-2028 (USD Billion)
10.3.4.5 France biotechnology reagents & kits market estimates and forecast, by purpose, 2017-2028 (USD Billion)
10.3.4.6 France biotechnology reagents & kits market estimates and forecast, by end-use, 2017-2028 (USD Billion)
10.3.5 Italy
10.3.5.1 Italy biotechnology reagents & kits market estimates and forecast, by kit type 2017-2028 (USD Billion)
10.3.5.2 Italy biotechnology reagents & kits market estimates and forecast, by technology 2017-2028 (USD Billion)
10.3.5.3 Italy biotechnology reagents & kits market estimates and forecast, by tested parameters, 2017-2028 (USD Billion)
10.3.5.4 Italy biotechnology reagents & kits market estimates and forecast, by micro-organisms, 2017-2028 (USD Billion)
10.3.5.5 Italy biotechnology reagents & kits market estimates and forecast, by purpose, 2017-2028 (USD Billion)
10.3.5.6 Italy biotechnology reagents & kits market estimates and forecast, by end-use, 2017-2028 (USD Billion)
10.3.6 Spain
10.3.6.1 Spain biotechnology reagents & kits market estimates and forecast, by kit type 2017-2028 (USD Billion)
10.3.6.2 Spain biotechnology reagents & kits market estimates and forecast, by technology 2017-2028 (USD Billion)
10.3.6.3 Spain biotechnology reagents & kits market estimates and forecast, by tested parameters, 2017-2028 (USD Billion)
10.3.6.4 Spain biotechnology reagents & kits market estimates and forecast, by micro-organisms, 2017-2028 (USD Billion)
10.3.6.5 Spain biotechnology reagents & kits market estimates and forecast, by purpose, 2017-2028 (USD Billion)
10.3.6.6 Spain biotechnology reagents & kits market estimates and forecast, by end-use, 2017-2028 (USD Billion)
10.4 Asia Pacific
10.4.1 Asia Pacific market estimates and forecasts, 2017 - 2028 (USD Billion)
10.4.2 Japan
10.4.2.1 Japan biotechnology reagents & kits market estimates and forecast, by kit type 2017-2028 (USD Billion)
10.4.2.2 Japan biotechnology reagents & kits market estimates and forecast, by technology 2017-2028 (USD Billion)
10.4.2.3 Japan biotechnology reagents & kits market estimates and forecast, by tested parameters, 2017-2028 (USD Billion)
10.4.2.4 Japan biotechnology reagents & kits market estimates and forecast, by micro-organisms, 2017-2028 (USD Billion)
10.4.2.5 Japan biotechnology reagents & kits market estimates and forecast, by purpose, 2017-2028 (USD Billion)
10.4.2.6 Japan biotechnology reagents & kits market estimates and forecast, by end-use, 2017-2028 (USD Billion)
10.4.3 China
10.4.3.1 China biotechnology reagents & kits market estimates and forecast, by kit type 2017-2028 (USD Billion)
10.4.3.2 China biotechnology reagents & kits market estimates and forecast, by technology 2017-2028 (USD Billion)
10.4.3.3 China biotechnology reagents & kits market estimates and forecast, by tested parameters, 2017-2028 (USD Billion)
10.4.3.4 China biotechnology reagents & kits market estimates and forecast, by micro-organisms, 2017-2028 (USD Billion)
10.4.3.5 China biotechnology reagents & kits market estimates and forecast, by purpose, 2017-2028 (USD Billion)
10.4.3.6 China biotechnology reagents & kits market estimates and forecast, by end-use, 2017-2028 (USD Billion)
10.4.4 India
10.4.4.1 India biotechnology reagents & kits market estimates and forecast, by kit type 2017-2028 (USD Billion)
10.4.4.2 India biotechnology reagents & kits market estimates and forecast, by technology 2017-2028 (USD Billion)
10.4.4.3 India biotechnology reagents & kits market estimates and forecast, by tested parameters, 2017-2028 (USD Billion)
10.4.4.4 India biotechnology reagents & kits market estimates and forecast, by micro-organisms, 2017-2028 (USD Billion)
10.4.4.5 India biotechnology reagents & kits market estimates and forecast, by purpose, 2017-2028 (USD Billion)
10.4.4.6 India biotechnology reagents & kits market estimates and forecast, by end-use, 2017-2028 (USD Billion)
10.4.5 Australia
10.4.5.1 Australia biotechnology reagents & kits market estimates and forecast, by kit type 2017-2028 (USD Billion)
10.4.5.2 Australia biotechnology reagents & kits market estimates and forecast, by technology 2017-2028 (USD Billion)
10.4.5.3 Australia biotechnology reagents & kits market estimates and forecast, by tested parameters, 2017-2028 (USD Billion)
10.4.5.4 Australia biotechnology reagents & kits market estimates and forecast, by micro-organisms, 2017-2028 (USD Billion)
10.4.5.5 Australia biotechnology reagents & kits market estimates and forecast, by purpose, 2017-2028 (USD Billion)
10.4.5.6 Australia biotechnology reagents & kits market estimates and forecast, by end-use, 2017-2028 (USD Billion)
10.5 Latin America
10.5.1 Latin America market estimates and forecasts, 2017 - 2028 (USD Billion)
10.5.2 Brazil
10.5.2.1 Brazil biotechnology reagents & kits market estimates and forecast, by kit type 2017-2028 (USD Billion)
10.5.2.2 Brazil biotechnology reagents & kits market estimates and forecast, by technology 2017-2028 (USD Billion)
10.5.2.3 Brazil biotechnology reagents & kits market estimates and forecast, by tested parameters, 2017-2028 (USD Billion)
10.5.2.4 Brazil biotechnology reagents & kits market estimates and forecast, by micro-organisms, 2017-2028 (USD Billion)
10.5.2.5 Brazil biotechnology reagents & kits market estimates and forecast, by purpose, 2017-2028 (USD Billion)
10.5.2.6 Brazil biotechnology reagents & kits market estimates and forecast, by end-use, 2017-2028 (USD Billion)
10.5.3 Mexico
10.5.3.1 Mexico biotechnology reagents & kits market estimates and forecast, by kit type 2017-2028 (USD Billion)
10.5.3.2 Mexico biotechnology reagents & kits market estimates and forecast, by technology 2017-2028 (USD Billion)
10.5.3.3 Mexico biotechnology reagents & kits market estimates and forecast, by tested parameters, 2017-2028 (USD Billion)
10.5.3.4 Mexico biotechnology reagents & kits market estimates and forecast, by micro-organisms, 2017-2028 (USD Billion)
10.5.3.5 Mexico biotechnology reagents & kits market estimates and forecast, by purpose, 2017-2028 (USD Billion)
10.5.3.6 Mexico biotechnology reagents & kits market estimates and forecast, by end-use, 2017-2028 (USD Billion)
10.6 Middle East and Africa (MEA)
10.6.1 MEA market estimates and forecasts, 2017 - 2028 (USD Billion)
10.6.2 South Africa
10.6.2.1 South Africa biotechnology reagents & kits market estimates and forecast, by kit type 2017-2028 (USD Billion)
10.6.2.2 South Africa biotechnology reagents & kits market estimates and forecast, by technology 2017-2028 (USD Billion)
10.6.2.3 South Africa biotechnology reagents & kits market estimates and forecast, by tested parameters, 2017-2028 (USD Billion)
10.6.2.4 South Africa biotechnology reagents & kits market estimates and forecast, by micro-organisms, 2017-2028 (USD Billion)
10.6.2.5 South Africa biotechnology reagents & kits market estimates and forecast, by purpose, 2017-2028 (USD Billion)
10.6.2.6 South Africa biotechnology reagents & kits market estimates and forecast, by end-use, 2017-2028 (USD Billion)
10.6.3 Saudi Arabia
10.6.3.1 Saudi Arabia biotechnology reagents & kits market estimates and forecast, by kit type 2017-2028 (USD Billion)
10.6.3.2 Saudi Arabia biotechnology reagents & kits market estimates and forecast, by technology 2017-2028 (USD Billion)
10.6.3.3 Saudi Arabia biotechnology reagents & kits market estimates and forecast, by tested parameters, 2017-2028 (USD Billion)
10.6.3.4 Saudi Arabia biotechnology reagents & kits market estimates and forecast, by micro-organisms, 2017-2028 (USD Billion)
10.6.3.5 Saudi Arabia biotechnology reagents & kits market estimates and forecast, by purpose, 2017-2028 (USD Billion)
10.6.3.6 Saudi Arabia biotechnology reagents & kits market estimates and forecast, by end-use, 2017-2028 (USD Billion)
Chapter 11 Competitive Landscape
11.1 Strategy Framework
11.2 Market Participation Categorization
11.3 Company Profiles
11.3.1 Thermo fisher scientific, Inc.
11.3.1.1 Company overview
11.3.1.2 Financial performance
11.3.1.3 Product benchmarking
11.3.1.4 Strategic initiatives
11.3.2 Qiagen
11.3.2.1 Company overview
11.3.2.2 Financial performance
11.3.2.3 Product benchmarking
11.3.2.4 Strategic initiatives
11.3.3 New England Biolabs
11.3.3.1 Company overview
11.3.3.2 Financial performance
11.3.3.3 Product benchmarking
11.3.3.4 Strategic initiatives
11.3.4 Illumina, Inc.
11.3.4.1 Company overview
11.3.4.2 Financial performance
11.3.4.3 Product benchmarking
11.3.4.4 Strategic initiatives
11.3.5 Agilent Technologies, Inc.
11.3.5.1 Company overview
11.3.5.2 Financial performance
11.3.5.3 Product benchmarking
11.3.5.4 Strategic initiatives
11.3.6 Bio-Rad Laboratories, Inc.
11.3.6.1 Company overview
11.3.6.2 Financial performance
11.3.6.3 Product benchmarking
11.3.6.4 Strategic initiatives
11.3.7 F. Hoffmann-La Roche Ltd.
11.3.7.1 Company overview
11.3.7.2 Financial performance
11.3.7.3 Product benchmarking
11.3.7.4 Strategic initiatives
11.3.8 Merck KGaA
11.3.8.1 Company overview
11.3.8.2 Financial performance
11.3.8.3 Product benchmarking
11.3.8.4 Strategic initiatives
11.3.9 Promega Corporation
11.3.9.1 Company overview
11.3.9.2 Financial performance
11.3.9.3 Product benchmarking
11.3.9.4 Strategic initiatives
11.3.10 Takara Bio, Inc.
11.3.10.1 Company overview
11.3.10.2 Financial performance
11.3.10.3 Product benchmarking
11.3.10.4 Strategic initiatives
11.3.11 LGC Limited
11.3.11.1 Company overview
11.3.11.2 Financial performance
11.3.11.3 Product benchmarking
11.3.11.4 Strategic initiatives
11.3.12 Toyobo Co. Ltd.
11.3.12.1 Company overview
11.3.12.2 Financial performance
11.3.12.3 Product benchmarking
11.3.12.4 Strategic initiatives
